Courtney Phillips - 02 Sep 2026 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)

Reporting relationship: GC and Corp. Secretary
Issuer ticker: MAZE
Reported as of: 02 Sep 2026
Net transaction value: -$104,766
SEC form: 4
Accepted by SEC: 04 Sep 2026, 16:27:14 UTC
Prior SEC filing: 03 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Courtney Phillips

Key filing fact

Courtney Phillips filed Form 4 for Maze Therapeutics, Inc. (MAZE) on 04 Sep 2026.

Key facts

This page summarizes Courtney Phillips's Form 4 filing for Maze Therapeutics, Inc. (MAZE).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Sep 2026, 16:27.

Change

Previous filing in this sequence was filed on 03 Sep 2026.
Current net transaction value: -$104,766.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001782758 Primary reporting owner

Courtney Phillips

Relationship: GC and Corp. Secretary
Address: C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Signature: /s/ Courtney Phillips
Signature date: 04 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MAZE transaction

Common Stock

Sale

Transaction value: $45,841
Shares: -1,738
Change %: -16%
Price: $26.38
Shares after: 9,262
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F1, F2

MAZE transaction

Common Stock

Sale

Transaction value: $6,590
Shares: -243
Change %: -2.6%
Price: $27.12
Shares after: 9,019
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F1, F3

MAZE transaction

Common Stock

Sale

Transaction value: $51,766
Shares: -1,990
Change %: -22%
Price: $26.01
Shares after: 7,029
Date: 03 Sep 2026
Ownership: Direct
Footnotes: F1, F4

MAZE transaction

Common Stock

Sale

Transaction value: $567
Shares: -22
Change %: -0.31%
Price: $25.78
Shares after: 7,007
Date: 03 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $27.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.055 to $27.40 per share, inclusive.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.743 to $26.65 per share, inclusive.